How to Reconstitute Retatrutide With Bacteriostatic Water

To reconstitute retatrutide with bacteriostatic water, a fixed mass of lyophilized peptide sealed in a vial is dissolved by adding a measured volume of diluent, which converts the freeze-dried powder into a liquid solution at a concentration determined entirely by how much water was added. The vial’s printed mg strength never changes during this process — only the volume the peptide is dissolved into changes, and that volume is what sets the resulting mg/mL or mcg/mL figure a listing or calculator will reference afterward.

What Bacteriostatic Water Is and Why It Is Used

Bacteriostatic water is water for injection that contains a small added concentration of benzyl alcohol, which inhibits bacterial growth across repeated withdrawals from the same vial. That distinguishes it from plain sterile water, which is typically intended for single use once opened. Retatrutide vials are supplied as a lyophilized (freeze-dried) cake or powder rather than a ready liquid, so a diluent has to be added before any volume can be measured out with a syringe. Bacteriostatic water is the diluent most commonly referenced across retatrutide listings and vendor documentation, largely because its preservative content supports a vial being accessed more than once rather than needing to be entirely drawn down at once.

The Order of Steps a Reconstitution Description Follows

Vendor documentation and reference guides describing how to reconstitute retatrutide with bacteriostatic water generally lay out the same sequence, regardless of vial strength:

1. Confirm the vial’s printed mg strength and let both the vial and the bacteriostatic water reach room temperature if either has been refrigerated.
2. Wipe the rubber stopper of both the peptide vial and the bacteriostatic water vial with an alcohol swab.
3. Draw the intended diluent volume into a syringe, matching the volume called for by the concentration a reader wants to end up with.
4. Insert the needle into the peptide vial at an angle and let the water run down the interior glass wall rather than injecting it directly onto the powder, which reduces disruptive turbulence.
5. Let the vial sit undisturbed, then gently swirl it in a slow rotating motion until the powder has fully dissolved. Vigorous shaking is generally described as something to avoid, since it can degrade the peptide structure rather than simply speeding dissolution.
6. Inspect the resulting solution, which should appear clear, before treating the vial as ready to measure from.

Because this sequence is identical regardless of which mg strength or diluent volume is chosen, the arithmetic step — deciding how much bacteriostatic water to add — is really the only variable that changes the outcome from one reconstitution to the next.

Calculating Concentration From Vial Strength and Diluent Volume

The formula that connects a retatrutide vial’s mg strength to its post-reconstitution concentration is straightforward: concentration (mg/mL) equals vial strength (mg) divided by the volume of bacteriostatic water added (mL). The table below shows how the same formula produces different concentrations depending on the diluent volume chosen for a given vial strength.

Vial Strength	Bacteriostatic Water Added	Concentration (mg/mL)	Concentration (mcg/mL)
5 mg	1 mL	5 mg/mL	5,000 mcg/mL
5 mg	2 mL	2.5 mg/mL	2,500 mcg/mL
10 mg	2 mL	5 mg/mL	5,000 mcg/mL
15 mg	3 mL	5 mg/mL	5,000 mcg/mL
20 mg	5 mL	4 mg/mL	4,000 mcg/mL

Two rows in that table land on the same 5 mg/mL concentration despite different vial strengths, because the ratio of mg to mL is what determines concentration, not either number in isolation. A listing that only states a vial’s mg strength without also stating the diluent volume used has not actually described a concentration at all — both figures are required before the arithmetic can be completed.

Worked Example: From Vial and Diluent to Syringe Units

Take a 20 mg retatrutide vial reconstituted with 5 mL of bacteriostatic water, matching the last row of the table above.

20 mg ÷ 5 mL = 4 mg/mL, which converts to 4,000 mcg/mL (4 mg × 1,000 mcg per mg).

A standard U-100 insulin syringe is marked so that 100 units equals 1 mL, meaning each single unit line on the barrel represents 0.01 mL. At 4,000 mcg/mL, one unit contains: 0.01 mL × 4,000 mcg/mL = 40 mcg.

Checking that figure a second way confirms it: the full 5 mL of reconstituted solution holds 20 mg (20,000 mcg) total, spread across 500 total 0.01 mL increments (5 mL ÷ 0.01 mL per increment). 20,000 mcg ÷ 500 increments = 40 mcg per increment, matching the first calculation. Both routes agree on 40 mcg per syringe unit for a 20 mg vial reconstituted with 5 mL. An independent tool such as peptcalc.com can be used to cross-check this kind of calculation against a second source before relying on any single figure.

Choosing a Diluent Volume When a Listing Offers a Range

Some retatrutide listings state a single fixed diluent volume for a given vial strength, while others describe a range and leave the specific volume to the reader. In the latter case, the underlying formula still applies the same way — a smaller diluent volume concentrates the same fixed mg amount into fewer mL, producing a higher mg/mL and mcg/mL figure, while a larger diluent volume spreads that same fixed amount thinner, lowering the concentration. Neither choice changes how much peptide is present in the vial; it only changes how that fixed quantity is expressed once measured with a syringe. Vendors that also publish reconstitution guidance alongside their own retatrutide product listing typically state a recommended diluent volume up front, which removes the need to select one from a wider range.

After Reconstitution: Storage Notes Worth Recording

Once a retatrutide vial has been reconstituted with bacteriostatic water, most vendor guidance describes storing the resulting solution refrigerated rather than at room temperature, and using it within a stated window rather than indefinitely. Because the exact recommended window can differ between sources, recording the reconstitution date directly on the vial label — alongside the diluent volume used — gives a reader a reference point for both figures without needing to recall them separately later. That same record also makes it possible to recompute the concentration at any point using the vial-strength-over-diluent-volume formula described above, rather than relying on memory.

Summary

Reconstituting retatrutide with bacteriostatic water comes down to two fixed inputs — the vial’s printed mg strength and the mL volume of diluent added — combined through one formula to produce a concentration. The steps themselves (equilibrating temperature, directing the water along the vial wall, swirling rather than shaking) stay the same across every vial strength, while the diluent volume chosen is the only variable that determines whether the resulting solution reads as a higher or lower mg/mL figure once reconstitution is complete.